Skin Autofluorescence as Marker of Tissue Advanced Glycation End-Products Accumulation in Formerly Preeclamptic Women

REFERENCES

• Roberts JM, Redman WG. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341:1447–1451.
   PubMed Web of Science ®Google Scholar
• Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: Opportunities for intervention and screening? BMJ 2002; 325:157–160.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas J, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 2007; 335:974.
   PubMed Web of Science ®Google Scholar
• Van Pampus MG, Aarnoudse JG. Long-term outcomes after preeclampsia. Clin Obstet Gynecol 2005; 48:489–494.
   PubMed Web of Science ®Google Scholar
• Martin U, Davies C, Hayavi S, Hartland A, Dunne F. Is normal pregnancy atherogenic? Clin Sci 1999; 96:421–425.
   PubMed Web of Science ®Google Scholar
• Rodie VA, Freeman DJ, Sattar N, Greer I. Pre-eclampsia and cardiovascular disease metabolic syndrome of pregnancy? Atherosclerosis 2004; 175:189–202.
   PubMed Web of Science ®Google Scholar
• Price CL, Knight SC. Advanced glycation: A novel outlook on atherosclerosis. Curr Pharm Des 2007; 13:3681–3687.
   PubMed Web of Science ®Google Scholar
• Smit AJ, Lutgers HL. The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. Curr Med Chem 2004; 11:2767–2784.
   PubMed Web of Science ®Google Scholar
• Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004; 63:582–592.
   PubMed Web of Science ®Google Scholar
• Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 1999; 104:103–113.
   PubMed Web of Science ®Google Scholar
• Ueno H, Koyama H, Tanaka S, et al. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 2008; 57:1452–1457.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradio through Sp-1 in human vascular endothelial cells. J Biol Chem 2000; 275:25781–25790.
   PubMed Web of Science ®Google Scholar
• Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91:3527–3561.
   PubMed Web of Science ®Google Scholar
• Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA 2001; 285:1607–1612.
   PubMed Web of Science ®Google Scholar
• Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 2008:9–21.
   PubMed Web of Science ®Google Scholar
• Harsem NK, Braekke K, Torjussen T, Hanssen K, Staff AC. Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia. Hypertens Pregnancy 2008; 27:374–386
   PubMed Web of Science ®Google Scholar
• Cooke CL, Brockelsby JC, Baker PN, Davidge ST. The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. Hypertens Pregnancy 2003; 22:173–184.
   PubMed Web of Science ®Google Scholar
• Chekir C, Nakatsuka M, Noguchi S, et al. Accumulation of advanced glycation end products in women with preeclampsia: Possible involvement of placental oxidative and nitrative stress. Placenta 2006; 27:225–233.
   PubMed Web of Science ®Google Scholar
• Blaauw J, Smit AJ, van Pampus MG, et al. Skin autofluorescence, a marker of advanced glycation end products and oxidative stress, is increased in recently preeclamptic women. Am J Obstet Gynecol 2006; 195:717–722.
   PubMed Web of Science ®Google Scholar
• Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158:892–898.
   PubMed Web of Science ®Google Scholar
• Mulder DJ, Water TV, Lutgers HL, et al. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: An overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006; 8:523–535.
   PubMed Web of Science ®Google Scholar
• Blaauw J, van Pampus MG, Van Doormaal JJ, et al. Increased intima-media thickness after early-onset preeclampsia. Obstet Gynecol 2006; 107:1345–1351.
   PubMed Web of Science ®Google Scholar
• Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007; 50:1435–1441.
   PubMed Web of Science ®Google Scholar
• Den Hollander NC, Mulder DJ, Graaff R. Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. J Inherit Metab Dis 2007; 30:916–923.
   PubMed Web of Science ®Google Scholar
• Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000; 275:39027–39031.
   PubMed Web of Science ®Google Scholar
• Mulder DJ, van Haelst PL, Gross S, et al. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2008; 197:217–223.
   PubMed Web of Science ®Google Scholar
• Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47:1324–1330.
   PubMed Web of Science ®Google Scholar
• Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007; 30:107–112.
   PubMed Web of Science ®Google Scholar
• De Leeuw K, Graaff R, de Vries R, et al. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46:1551–1556.
   PubMed Web of Science ®Google Scholar
• Nienhuis HL, de Leeuw K, Bijzet J, et al. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts. Rheumatology (Oxford) 2008; 47:1554–1558.
   PubMed Web of Science ®Google Scholar
• Gerrits EG, Lutgers HL, Kleefstra N, et al. Skin advanced glycation end product accumulation in poorly reflected by glycemic control in type 2 diabetes patients (ZODIAC-9). J Diabetes Sci Technol 2008; 2:572–577.
   PubMedGoogle Scholar
• Elling SV, Powell FC. Physiological changes in the skin during pregnancy. Clin Dermatol 1997; 15:35–43.
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Seeger J, Waldeyer T. Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens 2008; 26:1824–1828.
   PubMed Web of Science ®Google Scholar
• Pertyńska-Marczewska M, Głowacka E, Sobczak M, Cypryk K, Wilczyński J. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am J Reprod Immunol 2009; 61(2):175–182.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Pearson GD, Cutler JA, Lindheimer MD. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 2003; 22:109–127.
   PubMed Web of Science ®Google Scholar
• Lampinen KH, Rönnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens 2006; 24:751–756.
   PubMed Web of Science ®Google Scholar
• Lutgers HL, Graaff R, Links TP, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 2006; 12:2654–2659.
   Google Scholar